Abbott Laboratories Net Income per Employee (ABT), current and historic results, rankings and more, Quarterly Fundamentals - CSIMarket
CSIMarket
 


Abbott Laboratories  (NYSE: ABT)
 

Abbott Laboratories Net Income per Employee

ABT's Quarterly Results, Trends, Rankings, Statistics
Abbott Laboratories's Income per employee fell in the first quarter 2026 on a trailing twelve month basis to $ 54,574, but the productivity of Abbott Laboratories's 115,000 employees remained above the company average.
The Healthcare sector has seen employees of 59 other companies achieving higher income per employee. While Abbott Laboratories's total ranking has deteriorated compared to the previous quarter from 1190 to 1300.


What is Income per Employee Ratio?






ABT Net Income per Employee (Mar 31 2026)
I. Quarter
(Dec 31 2025)
IV. Quarter
(Sep 30 2025)
III. Quarter
(Jun 30 2025)
II. Quarter
(Mar 31 2025)
I. Quarter
Y / Y Net Income Change -18.72 % -80.76 % -0.12 % 36.64 % 8.16 %
Net Income per Employee (TTM) $ 54,574 56,730 121,539 121,557 117,409
ABT's Total Ranking # 1300 # 1190 # 791 # 696 # 727
Seq. Net Income Change -39.36 % 8.03 % -7.59 % 34.26 % -85.64 %


ABT Net Income per Employee Company Ranking
Within: No.
Major Pharmaceutical Preparations Industry # 60
Healthcare Sector # 116
Overall Market # 1300

Net Income per Employee Statistics
High Average Low
$ 121,557 $ 39,635 $ 4,139
(Jun 30 2025)   (Mar 31 2018)







Companies with similar Income per Employee for 12 month ending Mar 31 2026, within Healthcare Sector Income per Employee Income 12 month ending Mar 31 2026Number of Employees Mar 31 2026
Lemaitre Vascular Inc   95,270.23 $ 62.402  Million 655 
Ani Pharmaceuticals Inc  94,997.94 $ 92.148  Million 970 
Dexcom Inc   83,819.82 $ 930.400  Million 11,100 
Biomarin Pharmaceutical Inc  83,434.34 $ 268.742  Million 3,221 
Progyny Inc   79,080.61 $ 67.693  Million 856 
Strata Critical Medical Inc   78,193.01 $ 46.994  Million 601 
Agilent Technologies inc   78,121.55 $ 1,414.000  Million 18,100 
Sarepta Therapeutics Inc   77,912.57 $ 65.057  Million 835 
Aveanna Healthcare Holdings Inc   74,712.57 $ 261.494  Million 3,500 
Alkermes Plc   74,497.56 $ 152.720  Million 2,050 
Medpace Holdings Inc   74,257.74 $ 460.398  Million 6,200 
Solventum Corporation  71,600.00 $ 1,432.000  Million 20,000 
Edwards Lifesciences Corporation  68,356.25 $ 1,093.700  Million 16,000 
Alpha Pro Tech Ltd   68,308.94 $ 8.402  Million 123 
Protalix Biotherapeutics inc   67,840.71 $ 15.332  Million 226 
Corcept Therapeutics Inc  63,946.58 $ 46.681  Million 730 
Abbvie Inc   63,877.19 $ 3,641.000  Million 57,000 
Embecta Corp   60,486.49 $ 111.900  Million 1,850 
Boston Scientific Corporation  60,322.03 $ 3,559.000  Million 59,000 
Stryker Corp  59,589.29 $ 3,337.000  Million 56,000 
Utah Medical Products Inc  59,278.69 $ 10.848  Million 183 
Pro dex Inc   58,262.14 $ 12.002  Million 206 
Waters Corporation  56,866.84 $ 449.248  Million 7,900 
Insulet Corporation  56,074.07 $ 302.800  Million 5,400 
Msa Safety Inc  54,827.92 $ 290.588  Million 5,300 
Abbott Laboratories  54,573.91 $ 6,276.000  Million 115,000 
Vericel Corporation  53,924.62 $ 21.462  Million 398 
Mettler toledo International Inc   52,714.46 $ 875.060  Million 16,600 
Profound Medical Corp   52,123.46 $ 8.444  Million 162 
Electromed Inc   51,289.34 $ 10.104  Million 197 


Date modified: 2026-07-06T20:12:08+00:00




Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.